Sign in

CIK 0001815442

  • Large accelerated filer

Kymera Therapeutics, Inc.

Sign in to watch
Ticker
KYMR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812992166
Phone
+1 857-285-5314
Business address
500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN, MA, 02472
Former names
Kymera Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,158,214
in 2 filings, $3.4M under 10b5-1 plans

Net −$4,158,214. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 68 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-06-18 Morgan Leigh Director Grant or award · Stock Option (Right to Buy) +16,000 16,000
2024-06-18 Sandor Victor Director Grant or award · Stock Option (Right to Buy) +16,000 16,000
2024-06-18 Esposito Pamela Director Grant or award · Stock Option (Right to Buy) +16,000 16,000
2024-06-18 Mainolfi Nello Chief Executive Officer Exercise or conversion +14,413 $2.08 $30K 631,186
2024-06-18 Mainolfi Nello Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −14,413 505,559
2024-06-13 Booth Bruce Director Sale 10b5-1 −8,430 $34.98 $295K 4,548,400
2024-06-13 Booth Bruce Director Sale 10b5-1 −1,770 $34.98 $62K 802,022
2024-06-12 Booth Bruce Director Sale 10b5-1 −11,838 $35.35 $418K 4,558,827
2024-06-12 Booth Bruce Director Sale 10b5-1 −1,997 $36.02 $72K 4,556,830
2024-06-12 Booth Bruce Director Sale 10b5-1 −2,485 $35.35 $88K 804,212
2024-06-12 Booth Bruce Director Sale 10b5-1 −420 $36.02 $15K 803,792
2024-06-07 Horobin Joanna Director Exercise or conversion 10b5-1 +8,500 $2.08 $18K 8,500
2024-06-07 Horobin Joanna Director Sale 10b5-1 −2,187 $32.65 $71K 6,313
2024-06-07 Horobin Joanna Director Sale 10b5-1 −6,313 $33.11 $209K 0
2024-06-07 Horobin Joanna Director Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −8,500 33,195
2024-05-23 Chadwick Jeremy G Chief Operating Officer Sale −2,575 $34.99 $90K 44,183
2024-03-28 BAKER BROS. ADVISORS LP Director Grant or award · Non-Qualified Stock Option (right to buy) +32,000 32,000
2024-03-28 BAKER BROS. ADVISORS LP Director Grant or award · Non-Qualified Stock Option (right to buy) +32,000 32,000
2024-03-15 Booth Bruce Director Sale 10b5-1 −8,126 $39.31 $319K 4,621,849
2024-03-15 Booth Bruce Director Sale 10b5-1 −49,591 $40.62 $2.0M 4,572,258

Page 27 of 41 · 810 trades